Unveiling Gambogenic Acid as a Promising Antitumor Compound: A Review
Planta Medica · 01.05.2024 · 90 (05) · 353-367
DOI: 10.1055/a-2258-6663 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Planta Medica, erschienen am 01.05.2024. Verfasst von Li Mi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thyroid Surgery, Department of General Surgery and Laboratory of Thyroid and Parathyroid Disease, Frontiers Science Center for Disease-Re…. Hauptthemen laut MEDLINE: Xanthenes, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 99 Literaturangaben. Gefördert von: 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University, the project of West China Hospital, Foundation of Sichuan University.
Abstract (Originalsprache)
Gambogenic acid is a derivative of gambogic acid, a polyprenylated xanthone isolated from Garcinia hanburyi. Compared with the more widely studied gambogic acid, gambogenic acid has demonstrated advantages such as a more potent antitumor effect and less systemic toxicity than gambogic acid according to early investigations. Therefore, the present review summarizes the effectiveness and mechanisms of gambogenic acid in different cancers and highlights the mechanisms of action. In addition, drug delivery systems to improve the bioavailability of gambogenic acid and its pharmacokinetic profile are included. Gambogenic acid has been applied to treat a wide range of cancers, such as lung, liver, colorectal, breast, gastric, bladder, and prostate cancers. Gambogenic acid exerts its antitumor effects as a novel class of enhancer of zeste homolog 2 inhibitors. It prevents cancer cell proliferation by inducing apoptosis, ferroptosis, and necroptosis and controlling the cell cycle as well as autophagy. Gambogenic acid also hinders tumor cell invasion and metastasis by downregulating metastasis-related proteins. Moreover, gambogenic acid increases the sensitivity of cancer cells to chemotherapy and has shown effects on multidrug resistance in malignancy. This review adds insights for the prevention and treatment of cancers using gambogenic acid.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Thyroid Surgery, Department of General Surgery and Laboratory of Thyroid and Parathyroid Disease, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chen…
ORCID-Profile: Li Mi
Förderung
- 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University
- the project of West China Hospital
- Foundation of Sichuan University
Zitieren
APA
Mi, L., Xing, Z., Zhang, Y., He, T., Su, A., Wei, T., Li, Z., & Wu, W. (2024). Unveiling Gambogenic Acid as a Promising Antitumor Compound: A Review. Planta Medica, 90(05), 353-367. https://doi.org/10.1055/a-2258-6663
Vancouver
Mi L, Xing Z, Zhang Y, He T, Su A, Wei T, et al. Unveiling Gambogenic Acid as a Promising Antitumor Compound: A Review. Planta Medica. 2024;90(05):353-367. doi:10.1055/a-2258-6663
BibTeX
@article{Mi2024,
author = {Mi, Li and Xing, Zhichao and Zhang, Yujie and He, Ting and Su, Anping and Wei, Tao and Li, Zhihui and Wu, Wenshuang},
title = {Unveiling Gambogenic Acid as a Promising Antitumor Compound: A Review},
journal = {Planta Medica},
year = {2024},
volume = {90},
number = {05},
pages = {353--367},
doi = {10.1055/a-2258-6663}
}
EUVIMED